Mechanisms of Ibrutinib Resistance in Chronic Lymphocytic Leukemia
1 Views
administrator
07/14/23
The panelists, William G. Wierda, MD, PhD; Thomas J. Kipps, MD, PhD; Richard R. Furman, MD; Alessandra Ferrajoli, MD; and Shuo Ma, MD, PhD, analyze mechanisms of ibrutinib resistance in chronic lymphocytic leukemia.
Show more
Facebook Comments
No comments found